cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Horizon Therapeutics Public Ltd Co
15 own
24 watching
Current Price
$0
$0.09
(0.09%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
22,725.06M
52-Week High
52-Week High
113.83
52-Week Low
52-Week Low
57.84
Average Volume
Average Volume
0.13M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
47.3668
iconMarket Capitalization22,725.06M
icon52-Week High113.83
icon52-Week Low57.84
iconAverage Volume0.13M
iconDividend Yield--
iconP/E Ratio47.3668
What does the Horizon Therapeutics Public Ltd Co do?
Horizon Pharma Public Limited Company, a biopharmaceutical company, engages in identifying, developing, acquiring, and commercializing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases in the United States and internationally. The company's marketed medicine portfolio consists of ACTIMMUNE for the treatment of chronic granulomatous disease and malignant osteopetrosis; RAVICTI and BUPHENYL/AMMONAPS to treat urea cycle disorders; PROCYSBI for the treatment of nephropathic cystinosis; QUINSAIR for the treatment of chronic pulmonary infections due to pseudomonas aeruginosa in cystic fibrosis patients; and KRYSTEXXA to treat chronic refractory gout. Its products also include RAYOS/LODOTRA for the treatment of rheumatoid arthritis, polymyalgia rheumatic, systemic lupus erythematosus, and multiple other indications; DUEXIS to treat signs and symptoms of osteoarthritis and rheumatoid arthritis; MIGERGOT for the treatment of vascular headache; PENNSAID 2% to treat pain of osteoarthritis of the knees; and VIMOVO for the treatment of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The company has collaboration agreements with Fox Chase Cancer Center to study ACTIMMUNE in combination with PD-1/PD-L1 inhibitors for use in the treatment of various forms of cancer; and Alliance for Lupus Research (ALR) to study the effect of RAYOS on the fatigue experienced by systemic lupus erythematosus (SLE) patients. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
Read More
How much money does Horizon Therapeutics Public Ltd Co make?
News & Events about Horizon Therapeutics Public Ltd Co.
Business Wire
1month ago
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first patient has enrolled in a Phase 2 randomized placebo-controlled trial to evaluate its development-stage medicine daxdilimab, a potentially first-in-class, fully human monoclonal antibody targeting immunoglobulin-like transcript 7...
Business Wire
1month ago
Horizon Therapeutics plc (NASDAQ: HZNP): IRISH TAKEOVER PANEL DEALING DISCLOSURE UNDER RULE 8.1(c) AND (d)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR, OFFEREE OR PARTIES ACTING IN CONCERT WITH THEM IN RESPECT OF DEALINGS FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS...
Business Wire
1month ago
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the first patient has been enrolled in a Phase 3 clinical trial in Japan evaluating TEPEZZA for the treatment of adults with chronic Thyroid Eye Disease (TED) and low clinical activity score (CAS), which is a measure of disease activity...
Zolmax
1month ago
StockNews.com started coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP Get Rating) in a report published on Wednesday. The firm issued a buy rating on the biopharmaceutical companys stock. Horizon Therapeutics Public Price Performance Shares of NASDAQ:HZNP opened at $111.86 on ...
Business Wire
1month ago
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the Indications and Usage section of the TEPEZZA label to specify its use for the treatment of Thyroid Eye Disease regardless of Thyroid Eye Disease activity or...
Frequently Asked Questions
Frequently Asked Questions
What is Horizon Therapeutics Public Ltd Co share price today?
plus_minus_icon
Can Indians buy Horizon Therapeutics Public Ltd Co shares?
plus_minus_icon
How can I buy Horizon Therapeutics Public Ltd Co shares from India?
plus_minus_icon
Can Fractional shares of Horizon Therapeutics Public Ltd Co be purchased?
plus_minus_icon
What are the documents required to start investing in Horizon Therapeutics Public Ltd Co stocks?
plus_minus_icon
What is today’s traded volume of Horizon Therapeutics Public Ltd Co?
plus_minus_icon
What is today’s market capitalisation of Horizon Therapeutics Public Ltd Co?
plus_minus_icon
What is the 52-Week High and Low Range of Horizon Therapeutics Public Ltd Co?
plus_minus_icon
What percentage is Horizon Therapeutics Public Ltd Co down from its 52-Week High?
plus_minus_icon
What percentage is Horizon Therapeutics Public Ltd Co up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.09
(0.09%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00